The failure was Dimebon's second in a phase 3 trial.

WSJ: Medivation, Pfizer Alzheimer's Drug Fails to Meet Study Goals

Recall that a few patients in the phase III study presented last fall at ACR also experienced heart failure, but that TNFs are also associated with heart failure.

FORBES: Pfizer's Key Drug Walks A Tightrope

Genzyme is itself involved in a European 300-patient phase II trial that attempts to use skeletal muscle cells from the leg to prevent heart failure.

FORBES: Small Stem Cells Find Big Backers